arrow
A

Alysia Bosworth

city of hope
H指数:12
被引数:1,191

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or marrow transplant survivors and non-cancer controls

酪氨酸激酶抑制剂治疗的慢性髓性白血病患者的健康状况受损情况与血液或骨髓移植幸存者及非癌症对照者的比较

Leukemia
IF13.4
2026-08-210
OAAI
The Influence of Race/Ethnicity and Social Vulnerability on Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant in Older (≥60 Years) Adults

种族/族裔和社会脆弱性对老年(≥60岁)异基因造血细胞移植后非复发死亡率的影响

2026-05-280
PRE
Association of clonal haematopoiesis and diabetes with outcomes after autologous haematopoietic cell transplantation
2025-12-010
OAAI
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma

淋巴瘤自体移植幸存者中的克隆性造血及随后发生的静脉血栓栓塞症

2025-09-011
PRE
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation

克隆性造血与自体造血干细胞移植后非髓系继发性恶性肿瘤的风险

2025-08-010
OAAI
Clonal Hematopoiesis and Risk of Heart Failure After Autologous Hematopoietic Cell Transplantation for Lymphoma

克隆性造血与自体造血细胞移植治疗淋巴瘤后心力衰竭的风险

2025-01-010
OAAI
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies- a BMT Survivor Study (BMTSS)

淋巴恶性肿瘤造血干细胞移植(BMT)幸存者高风险健康行为的预测因素——造血干细胞移植幸存者研究(BMTSS)

BLOOD
IF23.1
2024-11-050
PRE
Long-Term Health Outcomes in Older (≥60 Years) Blood or Marrow Transplantation (BMT) Recipients: A Report from the Blood or Marrow Transplant Survivor Study (BMTSS)

≥60岁血液或骨髓移植(BMT)受者长期健康结局:血液或骨髓移植幸存者研究(BMTSS)报告

BLOOD
IF23.1
2024-11-050
PRE
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies- a BMT Survivor Study (BMTSS)

髓系恶性肿瘤的血或骨髓移植(BMT)幸存者中危险健康行为的影响因素——一项BMT幸存者研究(BMTSS)

BLOOD
IF23.1
2024-11-050
PRE
Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy

克隆性造血与嵌合抗原受体T细胞 (CART) 治疗患者的严重细胞因子释放综合征相关

2024-09-013
PRE